Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

You Tang

Showing results (361-370 of 440) with videos related to

Pageof 44
Sort By:
International Journal of Nanomedicine|August 14, 2012
The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs)Haitham Amal, Lu Ding, Bin-bin Liu, et al.
Hepatology (Baltimore, Md.)|January 8, 2008
Identification of metastasis-related microRNAs in hepatocellular carcinomaAnuradha Budhu, Hu-Liang Jia, Marshonna Forgues, et al.
Journal of Cancer Research and Clinical Oncology|May 22, 2010
Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expressionYu-Quan Xiong, Hui-Chuan Sun, Xiao-Dong Zhu, et al.
Cell Death & Disease|May 1, 2018
The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis targetCheng-Dong Qin, De-Ning Ma, Shi-Zhe Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinomaJin-Zhong Pang, Lun-Xiu Qin, Ning Ren, et al.
Cancer|September 2, 2006
P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinomaYong-Bing Qian, Ju-Bo Zhang, Wei-Zhong Wu, et al.
Proteomics|October 20, 2006
Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitroJie Feng Cui, Yin Kun Liu, Li Jun Zhang, et al.
Acta Pharmacologica Sinica|November 30, 2018
C11, a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor, suppresses breast cancer metastasis and angiogenesisZhuo Chen, Lin-Jiang Tong, Bai-You Tang, et al.
Plos One|April 5, 2013
The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinomaLing-Qun Kong, Xiao-Dong Zhu, Hua-Xiang Xu, et al.
Plos One|August 14, 2013
Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancerWen-Quan Wang, Liang Liu, Hua-Xiang Xu, et al.
Pageof 44

Showing results (361-370 of 440) with videos related to

Sort By:
Pageof 44
International Journal of Nanomedicine|August 14, 2012
The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs)Haitham Amal, Lu Ding, Bin-bin Liu, et al.
Hepatology (Baltimore, Md.)|January 8, 2008
Identification of metastasis-related microRNAs in hepatocellular carcinomaAnuradha Budhu, Hu-Liang Jia, Marshonna Forgues, et al.
Journal of Cancer Research and Clinical Oncology|May 22, 2010
Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expressionYu-Quan Xiong, Hui-Chuan Sun, Xiao-Dong Zhu, et al.
Cell Death & Disease|May 1, 2018
The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis targetCheng-Dong Qin, De-Ning Ma, Shi-Zhe Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinomaJin-Zhong Pang, Lun-Xiu Qin, Ning Ren, et al.
Cancer|September 2, 2006
P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinomaYong-Bing Qian, Ju-Bo Zhang, Wei-Zhong Wu, et al.
Proteomics|October 20, 2006
Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitroJie Feng Cui, Yin Kun Liu, Li Jun Zhang, et al.
Acta Pharmacologica Sinica|November 30, 2018
C11, a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor, suppresses breast cancer metastasis and angiogenesisZhuo Chen, Lin-Jiang Tong, Bai-You Tang, et al.
Plos One|April 5, 2013
The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinomaLing-Qun Kong, Xiao-Dong Zhu, Hua-Xiang Xu, et al.
Plos One|August 14, 2013
Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancerWen-Quan Wang, Liang Liu, Hua-Xiang Xu, et al.
Pageof 44